A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer.
Jouve
M
M
Dorval
T
T
Mosseri
V
V
Palangie
T
T
Beuzeboc
P
P
Garcia-Giralt
E
E
Livartowski
A
A
Scholl
S
S
Pouillart
P
P
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D016879:Salvage Therapy
D005047:Etoposide; D002945:Cisplatin; D008727:Methotrexate